Ustekinumab 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FG9DM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,211
Award facts
- Contract value 100% obligated
- $26,210.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $26,210.60 delivery order to Amerisourcebergen Drug Corp on June 1, 2026, for Ustekinumab 90 mg/ml syringes, with an ultimate completion date of June 23, 2026.
This is a firm fixed-price delivery order issued under DLA's pharmaceutical supply contract vehicle. Place of performance is Conshohocken, PA. The order represents a transactional pharmaceutical call against DLA's standing indefinite delivery infrastructure supporting military healthcare supply.
Quick answers
Who was awarded contract SPE2DR26FG9DM?
SPE2DR26FG9DM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 1, 2026.
How much is contract SPE2DR26FG9DM worth?
The government has obligated $26,211 on SPE2DR26FG9DM.
Is contract SPE2DR26FG9DM an order under another contract?
Yes. SPE2DR26FG9DM is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG9DM competed?
The extent of competition for SPE2DR26FG9DM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award